Healthcare ❯Pharmaceuticals ❯Cancer Treatment ❯Keytruda

Sales Performance

Pfizer and Merck Diverge in Q2 Performance Amid Revised Forecasts

Merck to Acquire EyeBio for Up to $3 Billion